• Bsa I (RNase-free): Practical Workflow Guide

  2026-08-20

  Bsa I (RNase-free) provides site-specific DNA cleavage for gene cloning and other DNA manipulation workflows in which RNA contamination should be minimized. It is intended for controlled molecular biology research, not diagnostic, clinical, or medical use.

• TMRE mitochondrial membrane potential assay kit Guide

  2026-08-19

  Build a quantitative workflow for measuring mitochondrial membrane potential in apoptosis, necrosis, and metabolic-stress models. This guide shows how to use TMRE with CCCP controls, plate-reader or imaging workflows, and orthogonal validation to distinguish true mitochondrial depolarization from loading and cell-number artifacts.

• Annexin V-Cy5: Translating Apoptosis Signals

  2026-08-19

  A mechanistic and strategic guide to using phosphatidylserine exposure as a decision point in microglial lysosomal-stress research, with practical guidance for flow cytometry, fluorescence microscopy, and translational assay design.

• PHF2 Links Neuroinflammation to Alzheimer’s Disease

  2026-08-18

  This Molecular Psychiatry study identifies the histone demethylase PHF2 as a regulator of inflammatory gene expression in Alzheimer’s disease and connects its activity to synaptic and cognitive outcomes. By combining human, cellular, genomic, and mouse-model evidence, the authors show that Phf2 knockdown suppresses neuroinflammation and improves spatial memory in 5xFAD mice.

• Polybrene: Better Delivery, Better Degrader Assays

  2026-08-18

  Polybrene (Hexadimethrine Bromide) is more than a viral transduction additive: it can be treated as a controllable delivery variable in chemical-biology assays. This article connects its electrostatic mechanism with rigorous targeted protein degradation experiments and practical assay design.

• Cy3-dCTP for Direct Fluorescent DNA Labeling

  2026-08-17

  Cy3-dCTP enables direct fluorescent incorporation during PCR, reverse transcription, and Nick Translation, reducing the handling steps required for probe generation. This application guide combines practical labeling workflows with a cautious translation of ordered DNA-framework research into assay design decisions.

• CB-5083 and the Proteostasis–Stress Granule Axis

  2026-08-17

  CB-5083 offers a translational route to interrogate p97-dependent protein quality control, connecting proteostasis disruption, ER stress, stress-granule dynamics, and tumor biology. This article outlines evidence, experimental workflows, model-selection logic, and limitations for oncology and multiple myeloma research.

• Dabigatran Etexilate in Thrombin Assays

  2026-08-16

  Dabigatran etexilate provides a concentration-responsive way to interrogate thrombin activity, platelet aggregation, and plasma clotting in translational studies. This guide converts its direct thrombin inhibitor profile into practical assay workflows, controls, and troubleshooting strategies for atrial fibrillation and coagulation research.

• TBST in Translational Antibody Assays

  2026-08-15

  TBST (Tris-Buffered Saline and Tween 20) is more than a routine wash solution: it is a controllable variable in antibody-based evidence generation. This article connects buffer selection with the orthogonal biochemical, cellular, and in vivo validation strategy used to study uPAR–uPA inhibition in breast cancer metastasis.

• Plk1 Control of p31comet in Mitotic Checkpoint Disassembly

  2026-08-14

  The reference study identifies Polo-like kinase 1 (Plk1) as a direct negative regulator of p31comet-driven mitotic checkpoint complex disassembly. By linking Plk1 phosphorylation of p31comet at S102 to suppression of TRIP13-assisted Mad2 release, the work explains how cells may prevent premature checkpoint inactivation during mitosis.

• A-1331852: A Practical BCL-XL Inhibitor Workflow

  2026-08-14

  A-1331852 provides a selective way to test BCL-XL dependence, connect mitochondrial apoptosis measurements with mechanism, and design combination studies. This workflow translates findings from glioblastoma research into practical assay choices while emphasizing formulation, controls, and interpretation limits.

• Y-27632 ROCK Inhibitor Workflow Guide

  2026-08-13

  Use Y-27632 to separate ROCK-dependent cytoskeletal effects from membrane-targeting biology in reproducible cell assays. This guide connects reversible ROCK1/2 inhibition with stress-fiber analysis, cancer biology research, and practical validation of PD-L1 membrane-editing workflows.

• Epacadostat (INCB024360) for Immune Assays

  2026-08-13

  Epacadostat (INCB024360) enables a practical way to isolate IDO1-driven immune suppression from broader metabolic effects in whole-blood, cellular, and tumor-model workflows. Its strongest use-case is a staged assay strategy that connects biochemical inhibition with cytokine, T-cell, and checkpoint-combination readouts.

• Irinotecan (CPT-11): Mechanism and Research Use

  2026-08-12

  Irinotecan, also called CPT-11, is a carboxylesterase-activated topoisomerase I inhibitor used to investigate DNA damage, apoptosis, and colorectal cancer biology. Its research value is supported by cell-line cytotoxicity data, xenograft activity, and mechanistic studies linking treatment-associated liver injury to gut–liver axis dysfunction.

• CUDC-907: Practical Dual-Pathway Assay Guide

  2026-08-12

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of signaling, chromatin-associated responses, cell-cycle progression, and apoptosis. This guide translates the product dossier into an executable workflow and defines boundaries for interpretation; the compound is not intended for diagnostic, therapeutic, or clinical use.

8443 records 8/563 page Previous Next First page 上5页 678910 下5页 Last page